Methodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer risk

Cheng-Hsien HungChun-Ting LinJames Cheng-Chung Wei2026-02-042026-02-042024-1210.1016/j.phrs.2024.107481https://scholars.csmu.edu.tw/handle/123456789/5096[SDGs]SDG3Methodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer riskjournal-article